Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 14.93 Delayed Data As of 3:59pm ET |  +0.18 / +1.22%Today’s Change | 4.26 Today|||52-Week Range 15.65 | +37.35% Year-to-Date |
Latest ARCT News | Press Releases
No recent news for Arcturus Therapeutics Holdings Inc.
Today’s Trading
| Previous close | 14.75 |
| Today’s open | 14.73 |
| Day’s range | 14.23 - 15.01 |
| Volume | 72,539 |
| Average volume (3 months) | 70,406 |
| Market cap | $209.0M |
Data as of 3:59pm ET, 02/21/2020
Growth & Valuation
| Earnings growth (last year) | +38.71% |
| Earnings growth (this year) | +16.51% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +21.20% |
| P/E ratio | NM |
| Price/Sales | 2.90 |
| Price/Book | 10.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NYMXNymox Pharmaceutical... | 0.00 | 0.00% |
| LOGCLogicBio Therapeutic... | -0.89 | -9.24% |
| KLDOKaleido Biosciences ... | +0.03 | +0.42% |
| AGRXAgile Therapeutics I... | -0.48 | -13.55% |
Data as of 4:00pm ET, 02/21/2020
Financials
| Next reporting date | March 23, 2020 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $15.8M |
| Annual profit (last year) | -$21.8M |
| Net profit margin | -138.29% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
